SRC and colorectal carcinoma: Indeed, previous work from our group demonstrated that a high constitutive activation of SRC kinase was associated with resistance to oxaliplatin in CRC cell lines, and pharmacological inhibition of SRC sensitized CRC liver metastasis to oxaliplatin in orthotopically grown patient-derived xenograft (PDX) models [29].